openPR Logo
Press release

Soft Tissue Repair Market Study Offering Deep Insight Related to Growth Trends Until 2026

10-20-2022 11:40 AM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research (TMR) has published a new report titled, "Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026". According to the report, the global soft tissue repair market is anticipated expand at a CAGR of 6.3% from 2018 to 2026. High prevalence of sports and orthopedic injuries and increase prevalence of breast reconstruction and hernia repair are projected to augment the global market between 2018 and 2026.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14687

Rise in prevalence of breast reconstruction and hernia repair to propel the market

Increase in number of prevalence of breast reconstruction is driving the soft tissue repair market. The market Asia Pacific is expected to expand at a significant pace during the forecast period owing to the increase number of surgical procedures, such as hernia repair, rise in number of product offerings in China and Australia, and rapid development of the medical device industry.

Increase in prevalence of sports and orthopedic injuries

Increase in participation in sports and physical fitness activities are propelling the market for soft tissue repair. Rise in prevalence of sports injuries, increase in number of orthopedic procedures, and increase in geriatric population in emerging economics, such as China, India, and Australia, are anticipated to fuel the market in Asia Pacific.

Read Report Overview @ https://www.transparencymarketresearch.com/soft-tissue-repair-market.html

Available alternatives for soft tissue repair

Available alternatives for soft tissue repair restrains the soft tissue repair market. Alternative therapies, such as physiotherapy, orthopedic manual therapy, PRICE, i.e., protection, rest, ice, compression, and elevation, are hampering the market for soft tissue repair. Apart from this, painkiller such as non-steroidal anti-inflammatory drugs used to ease pain and reduce any swelling of acute soft tissue injuries. Additionally, corticosteroids injections can also be recommended for persistent inflammation, which ultimately restrains the market for soft tissue repair.

Technological advancements offer future opportunity

Technological advancements are projected to increase during the forecast period. ARTELON DYNAMIC MATRIX, a product of Artelon, has advantage over the suture and tissue graft. It maintains the natural stiffness and enhances the strength. Additionally, it provides a broad elastic profile, which promotes reproducible surgical tensioning. CelGro, a product of Orthocell, is a highly effective scaffold medical device. CelGro has the capability to enhance tissue growth and repair injuries.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=14687

Product launches and patent approval by key players to boost market

The report also provides profiles of leading players operating in the global soft tissue repair market. These include American Medical Systems Inc (Boston Scientific), Arthrex, Inc., C.R. Bard, Inc., Covidien plc (Medtornic), Depuy Synthesis (Johnson & Johnson), Integra LifeScience Corporation, LifeCell Corporation (Allergan), Smith & Nephew, Stryker, and Wright Medical Group N.V. New product launches and focus on developing technologically advanced product and patent approval are expected to drive the global market during the forecast period.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=14687

In November 2017, Orthocell Limited received approval from European regulatory for its CelGro collagen medical devices that are utilized for dental bone and soft tissue regeneration procedures. In January 2016, AlloSource, provider of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care, received U.S. patent for its new cartilage repair allograft, ProChondrix Cartilage Restoration Matrix.

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Soft Tissue Repair Market Study Offering Deep Insight Related to Growth Trends Until 2026 here

News-ID: 2773891 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Increase

Increase Rank Increase Sales Increase ROI With E-Commerce SEO Services
Setting up an eCommerce business is a big task and getting traffic towards your eCommerce store is yet another huge work. But you have to work upon getting more and more traffic towards your online store only then will you get orders for your business. For this you require quintessential SEO services that can be your partner and steer you in right direction through its on page scrutiny and removing
Increase in Geriatric Population will Likely Increase the Demand for Combination …
Combination drug also referred to as fixed dose combination (FDC), is a formulation which includes two or more active pharmaceutical ingredients (APIs). The dosage is distributed in certain fixed doses. Initially, fixed dose combination products were produced for targeting single diseases for example antiretroviral combination drugs were manufactured for targeting AIDS. However, with the advancements, in research and development activities currently combination drugs are being manufactured for targeting multiple disease
Accu Holding AG: Ordinary Capital increase and further capital measures to incre …
Ordinary Capital increase and further capital measures to increase shareholder's equity by more than CHF 10 million Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION IN THE UNITED STATES, UNITED KINGDOM OR THE EUROPEAN ECONOMIC AREA • Exercise of subscription rights within the expected range • Strengthening of the balance sheet through conversion of debt of CHF 5'379'953 into new
Pigs‘ Toys Increase Animal Wellbeing
Less Injuries in Pig Houses In cooperation with Kassel University, WEDA Dammann & Westerkamp, specialists for pig house equipment from Lutten, have developed a new kind of manipulable material for piglets and fattening pigs. By means of the rooting cones and pushing balls of bite-resistant and food-safe polyurethane, mounted to floor and brackets, the animals can act out their natural play instinct and can permanently busy themselves while standing up, sitting,
Increase in the ‘Staycation’
The new ‘buzz’ word ‘staycation’ as it is known, has become increasingly popular, with the cost of family holidays abroad on the increase, and the value of the pound weaker, families are choosing to holiday in the UK. Camping and caravanning in the UK is at the top of the list for a brilliant ‘staycation’. As the cut-backs start to take effect and everyone is feeling the pinch in their
PROPOSAL CAPITAL INCREASE
The Board of Directors of EXMAR has decided to propose to the shareholders to proceed with a capital increase of EUR 100 million. Saverex NV, the reference shareholder of EXMAR, will participate in the capital increase with an amount of EUR 50 million. Sofina SA will also participate in the transaction in accordance with its current shareholding in the company (approx. 1.3%). Sofina SA has confirmed a further support to